Physician profile
Brooke E Friedl
NPI 1386270320
$1,673.84
in general payments reported to CMS, 2019-2025
16 companies · $49.50 in 2025
The $49.50 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $572 · 2024: $1,052 · 2025: $49.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $281.83 | 2023-2024 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $249.28 | 2023-2025 | |
| Lilly USA, LLC | $245.13 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.30 | 2023-2024 | Jardiance, Tradjenta, Synjardy |
| Novo Nordisk INC | $208.49 | 2023-2024 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $70.06 | 2023-2024 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $63.19 | 2023-2024 | |
| Exact Sciences Corporation | $51.81 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $49.78 | 2023-2024 | Prolia, Evenity, Repatha |
| Lundbeck LLC | $48.40 | 2023-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $45.59 | 2023 | Rexulti |
| Astellas Pharma US INC | $44.00 | 2023-2024 | Veozah |
| Kowa Pharmaceuticals America, INC. | $28.11 | 2024 | Livalo, Zoryve |
| Pfizer INC. | $27.57 | 2024 | |
| Dexcom, INC. | $24.18 | 2024 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $19.12 | 2024 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Friedl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.